| Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system Y Zhou, KA Gammeltoft, LA Ryberg, LV Pham, HD Tjørnelund, A Binderup, ... Science advances 8 (51), eadd7197, 2022 | 134 | 2022 |
| Mouse models of acute and chronic hepacivirus infection E Billerbeck, R Wolfisberg, U Fahnøe, JW Xiao, C Quirk, JM Luna, ... Science 357 (6347), 204-208, 2017 | 122 | 2017 |
| In vitro efficacy of artemisinin-based treatments against SARS-CoV-2 Y Zhou, K Gilmore, S Ramirez, E Settels, KA Gammeltoft, LV Pham, ... Scientific Reports 11 (1), 14571, 2021 | 93 | 2021 |
| Overcoming culture restriction for SARS-CoV-2 in human cells facilitates the screening of compounds inhibiting viral replication S Ramirez, C Fernandez-Antunez, A Galli, A Underwood, LV Pham, ... Antimicrobial Agents and Chemotherapy 65 (7), 10.1128/aac. 00097-21, 2021 | 76 | 2021 |
| Evolutionary pathways to persistence of highly fit and resistant hepatitis C virus protease inhibitor escape variants SB Jensen, U Fahnøe, LV Pham, SBN Serre, Q Tang, L Ghanem, ... Hepatology 70 (3), 771-787, 2019 | 55 | 2019 |
| HCV genotype 6a escape from and resistance to velpatasvir, pibrentasvir, and sofosbuvir in robust infectious cell culture models LV Pham, S Ramirez, JM Gottwein, U Fahnøe, YP Li, J Pedersen, J Bukh Gastroenterology 154 (8), 2194-2208. e12, 2018 | 51 | 2018 |
| HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape LV Pham, SB Jensen, U Fahnøe, MS Pedersen, Q Tang, L Ghanem, ... Journal of Hepatology 70 (3), 388-397, 2019 | 41 | 2019 |
| Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro KA Gammeltoft, Y Zhou, CR Duarte Hernandez, A Galli, A Offersgaard, ... Antimicrobial Agents and Chemotherapy 65 (9), 10.1128/aac. 02680-20, 2021 | 40 | 2021 |
| Analysis of classical swine fever virus RNA replication determinants using replicons PC Risager, U Fahnøe, M Gullberg, TB Rasmussen, GJ Belsham Journal of General Virology 94 (8), 1739-1748, 2013 | 34 | 2013 |
| A fast and robust method for full genome sequencing of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Type 1 and Type 2 LK Kvisgaard, CK Hjulsager, U Fahnøe, SØ Breum, T Ait-Ali, LE Larsen Journal of virological methods 193 (2), 697-705, 2013 | 33 | 2013 |
| Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine K Lothert, AF Offersgaard, AF Pihl, CK Mathiesen, TB Jensen, GP Alzua, ... Scientific Reports 10 (1), 16261, 2020 | 30 | 2020 |
| Pathogenesis, MicroRNA‐122 gene‐regulation, and protective immune responses after acute equine hepacivirus infection JE Tomlinson, R Wolfisberg, U Fahnøe, RS Patel, S Trivedi, A Kumar, ... Hepatology 74 (3), 1148-1163, 2021 | 26 | 2021 |
| Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation C Sølund, S Hallager, MS Pedersen, U Fahnøe, A Ernst, HB Krarup, ... Scandinavian journal of gastroenterology 53 (7), 849-856, 2018 | 26 | 2018 |
| Rescue of the highly virulent classical swine fever virus strain “Koslov” from cloned cDNA and first insights into genome variations relevant for virulence U Fahnøe, AG Pedersen, PC Risager, J Nielsen, GJ Belsham, D Höper, ... Virology 468, 379-387, 2014 | 26 | 2014 |
| SARS-CoV-2 production in a scalable high cell density bioreactor A Offersgaard, CR Duarte Hernandez, AF Pihl, R Costa, NP Venkatesan, ... Vaccines 9 (7), 706, 2021 | 24 | 2021 |
| Full-length open reading frame amplification of hepatitis C virus U Fahnøe, J Bukh Hepatitis C Virus Protocols, 85-91, 2019 | 22 | 2019 |
| Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis JE Tomlinson, R Wolfisberg, U Fahnøe, H Sharma, RW Renshaw, ... PLoS pathogens 16 (7), e1008677, 2020 | 21 | 2020 |
| Efficacy of ion-channel inhibitors amantadine, memantine and rimantadine for the treatment of SARS-CoV-2 in vitro Y Zhou, KA Gammeltoft, A Galli, A Offersgaard, U Fahnøe, S Ramirez, ... Viruses 13 (10), 2082, 2021 | 20 | 2021 |
| Determinants of the VP1/2A junction cleavage by the 3C protease in foot-and-mouth disease virus-infected cells T Kristensen, P Normann, M Gullberg, U Fahnøe, C Polacek, ... Journal of General Virology 98 (3), 385-395, 2017 | 20 | 2017 |
| High density Huh7. 5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals AF Pihl, AF Offersgaard, CK Mathiesen, J Prentoe, U Fahnøe, H Krarup, ... Scientific reports 8 (1), 17505, 2018 | 19 | 2018 |
